Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 20.
doi: 10.1097/MCG.0000000000002317. Online ahead of print.

Radiographically-Measured Sarcopenia Predicts Hospitalization in Patients With Crohn's Disease

Aman S Bali  1 , Walaa G El Sheikh  2 , Ahmed Ouni  3 , Joshua Kwon  4 , Varun Moktan  5 , Frank Chen  6 , Francis A Farraye  7 , Hani Tamim  2 , Jana G Hashash  7
Affiliations

Radiographically-Measured Sarcopenia Predicts Hospitalization in Patients With Crohn's Disease

Aman S Bali et al. J Clin Gastroenterol. .

Abstract

Background and aims: Sarcopenia (SP) is increasingly recognized as a poor prognostic factor for patients with Crohn's disease (CD). We aimed to use radiographically-measured SP to determine a disease-specific definition and measure its association with CD-related outcomes.

Methods: This retrospective study included adults with CD seen at our outpatient tertiary center between 2019 and 2021 who underwent a CT scan within 3 months of visit. Using axial cross-sectional measurements at the L3 vertebral level, skeletal muscle area was indexed to height to derive skeletal muscle index (SMI). Demographics, comorbidities, CD phenotype, and outcomes, including hospitalization at 1 year, were analyzed in univariate and multivariate models.

Results: One hundred twenty-four patients with CD were included, with a mean age of 52.2±16.6 years and 53.2% (66/124) women. Overall, 33.1% (41/124) had SP based on sex-specific cutoffs with men representing 75.6% (31/41) of the sarcopenic population. In bivariate analysis, patients with SP had a higher likelihood of hospitalization (43.9% vs. 22.9% for non-SP, P=0.02) and penetrating CD phenotype (20.0% vs. 2.3% for non-SP, P<0.05). On multivariate regression, higher SMI was associated with decreased hospitalization, with each 10-unit increase in SMI conferring 0.54 lower odds (OR: 0.54 [95% CI: 0.32-0.92], P=0.02). Patients with higher SMI trended towards lower use of biologics (OR: 0.70 [95% CI: 0.45-1.09], P=0.12). Our novel SP definition derived from an IBD population performed similarly to definitions from the literature.

Conclusion: Our study demonstrates the application of an automated algorithm for the quantification of body composition based on CT scan in patients with CD. SP and low SMI were associated with increased hospitalization at 1 year.

Keywords: Crohn’s disease; body composition; hospitalization; sarcopenia.

PubMed Disclaimer

References

    1. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–558.
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
    1. Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1611–1644.
    1. Pierobon ES, Moletta L, Zampieri S, et al. The prognostic value of low muscle mass in pancreatic cancer patients: a systematic review and meta-analysis. J Clin Med. 2021;10:3033.
    1. Su H, Ruan J, Chen T, et al. CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging. 2019;19:82.

LinkOut - more resources